Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource]

author
Kovacovicova, Kristina
Heinmaa, Mihkel
Mistrik, Martin
statement of authorship
Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek and Manlio Vinciguerra
journal volume number month
vol. 8
year of publication
pages
art. 459, 7 p. : ill
keyword
NAFLD (non-alcoholic fatty liver disease)
HCC (hepatocellular carcinoma)
senolytic agents
quercertin
dasatinib
ISSN
2234-943X
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
kvartiil
Q1
language
inglise
Kovacovicova, K.; Školnaja, M.; Heinmaa, M.; Mistrik, M.; Pata, P.; Pata, I. et al. Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource] // Frontiers in oncology (2018) vol. 8, art. 459, 7 p. : ill. https://doi.org/10.3389/fonc.2018.00459